BIOMAY AG

ACTIVE

Ada-Lovelace-Straße 2, Wien, Austriawww.biomay.comPrivate

Clinical Trials

8 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

30.8%

Phase 2

30.8%

Trial Status Distribution

Active, not recruiting

61.5%

Completed

38.5%

Clinical Trials

Trials sponsored by this organization (13)

STUDY ON THE SAFETY AND EFFICACY OF BM32, A VACCINE FOR IMMUNOTHERAPY OF GRASS POLLEN ALLERGY

Phase 1

Active, not recruiting

Oct 2016180 participants

Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response

Phase 2

Completed

interventional

Jan 2016130 participants

Study to evaluate the effect of different pre-seasonal BM32 dosing schedules on the induction of a protective allergen-specific IgG Immune response

Phase 1

Active, not recruiting

Nov 2015

STUDY ON THE SAFETY AND EFFICACY OF BM32, A VACCINE FOR IMMUNOTHERAPY OF GRASS POLLEN ALLERGY

Phase 1

Active, not recruiting

Apr 2012180 participants

STUDY ON THE SAFETY AND EFFICACY OF BM32, A VACCINE FOR IMMUNOTHERAPY OF GRASS POLLEN ALLERGY

Active, not recruiting

Mar 2012180 participants

Phase II Study of Grass Pollen Allergy Vaccine BM32

Phase 2

Completed

interventional

Mar 2012181 participants

STUDY ON THE SAFETY AND EFFICACY OF BM32, A VACCINE FOR IMMUNOTHERAPY OF GRASS POLLEN ALLERGY

Active, not recruiting

Feb 2012180 participants

STUDY ON THE SAFETY AND EFFICACY OF BM32, A VACCINE FOR IMMUNOTHERAPY OF GRASS POLLEN ALLERGY

Active, not recruiting

Feb 2012180 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations